Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area
- PMID: 10574809
- PMCID: PMC1722897
- DOI: 10.1136/bjo.83.12.1332
Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area
Abstract
Background/aims: The World Health Organisation has recommended repeated mass treatment of children in trachoma endemic areas with oral azithromycin. While chlamydia, the causative agent of trachoma, remains universally sensitive to azithromycin, there is concern that large scale programmes may alter the bacterial flora and induce resistance in streptococcal species. In this study the effect of a single dose of azithromcyin on the prevalence, species distribution, and resistance of conjunctival bacterial flora was determined.
Methods: Baseline and 14 day follow up bacterial cultures were taken from the conjunctivae of 121 children who reside in a trachoma endemic area of Nepal. 91 children were treated with azithromycin at baseline and 31 children received deferred treatment at the 14 day follow up.
Results: Although the prevalence of bacterial pathogens decreased significantly with azithromycin treatment, a significant change in the distribution of specific bacterial pathogens could not be demonstrated. Streptococcal resistance to azithromycin was found significantly more frequently after treatment. No change in the prevalence, distribution, or resistance pattern was found in the untreated control group.
Conclusion: Repeated mass treatment of trachoma endemic areas with oral azithromycin will have an effect on bacterial flora. However, further work needs to be done to determine if this will have any clinical relevance.
Similar articles
-
Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.Br J Ophthalmol. 2003 Feb;87(2):147-8. doi: 10.1136/bjo.87.2.147. Br J Ophthalmol. 2003. PMID: 12543738 Free PMC article. Clinical Trial.
-
Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.Clin Infect Dis. 2013 Jun;56(11):1519-26. doi: 10.1093/cid/cit137. Epub 2013 Mar 13. Clin Infect Dis. 2013. PMID: 23487375
-
Mass treatment with single-dose azithromycin for trachoma.N Engl J Med. 2004 Nov 4;351(19):1962-71. doi: 10.1056/NEJMoa040979. N Engl J Med. 2004. PMID: 15525721 Free PMC article. Clinical Trial.
-
Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review.Lancet Infect Dis. 2019 Jan;19(1):e14-e25. doi: 10.1016/S1473-3099(18)30444-4. Epub 2018 Oct 3. Lancet Infect Dis. 2019. PMID: 30292480
-
Trachoma: a review.J Chemother. 2001 Apr;13 Suppl 1:18-22. doi: 10.1080/1120009x.2001.11782323. J Chemother. 2001. PMID: 11434524 Review.
Cited by
-
Azithromycin, fluoroquinolone and chloramphenicol resistance of non-chlamydia conjunctival bacteria in rural community of Ethiopia.Indian J Ophthalmol. 2014 Feb;62(2):236-9. doi: 10.4103/0301-4738.99974. Indian J Ophthalmol. 2014. PMID: 23571246 Free PMC article.
-
Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial.Br J Ophthalmol. 2007 May;91(5):667-72. doi: 10.1136/bjo.2006.099275. Epub 2006 Sep 27. Br J Ophthalmol. 2007. PMID: 17005549 Free PMC article. Clinical Trial.
-
Longitudinal study of trachomatous trichiasis in the Gambia.Br J Ophthalmol. 2002 Mar;86(3):339-43. doi: 10.1136/bjo.86.3.339. Br J Ophthalmol. 2002. PMID: 11864895 Free PMC article.
-
A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia.Br J Ophthalmol. 2005 Oct;89(10):1282-8. doi: 10.1136/bjo.2004.062489. Br J Ophthalmol. 2005. PMID: 16170117 Free PMC article. Clinical Trial.
-
What's new in azithromyin?Community Eye Health. 2004 Dec;17(52):54-6. Community Eye Health. 2004. PMID: 17491822 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical